High Tech Pharm Co Ltd banner
H

High Tech Pharm Co Ltd
KOSDAQ:106190

Watchlist Manager
High Tech Pharm Co Ltd
KOSDAQ:106190
Watchlist
Price: 13 900 KRW 3.04%
Market Cap: ₩147.8B

High Tech Pharm Co Ltd
Investor Relations

HIGH TECH PHARM Co., Ltd. engages in the manufacture and sale of raw materials for injectable antibiotic products. The company is headquartered in Chungju, Chungcheongbuk-Do and currently employs 99 full-time employees. The company went IPO on 2010-07-28. CO., LTD. is a Korea-based company mainly engaged in the manufacture of antibiotic pharmaceutical ingredients for injections. The firm's products include sterile imipenem, sterile cilastatin sodium, sterile blended imipenem and cilastatin sodium, injectable sterile meropenem, injectable sterile panipenem, faropenem and others. The firm distributes its products within domestic market and to overseas markets.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Jeong-Soo Kim
Chief Executive Officer
No Bio Available

Contacts

Address
CHUNGCHEONGBUK-DO
CHUNGJU
12, Cheomdansaneop 6-ro, Daesowon-myeon
Contacts
+82438800011
www.htpharm.com